why do people stop taking glp-1 drugs Can You Just GLP‑1 Drugs? What Really Happens in 2026 When You Come Off Ozempic, Wegovy & More What Happens When Patients Stop

Main outcome measures Cox proportional hazards models were fitted to estimate the hazard ratios and 95% confidence intervals of major adverse cardiovascular events and serious renal events, separately, comparing the GLP-1 receptor agonist-SGLT-2 inhibitor combination with the background drug, either GLP-1 receptor agonists or SGLT-2 inhibitors, depending on the cohort

Conflict of interest BG has served as a consultant for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck (MSD) and Novartis as manufacturers of DPP-4 inhibitors and has received honoraria from these companies for lectures

PlexusDx serves all 50 states without insurance requirements, and HSA/FSA funds are eligible, making flexible, personalized treatment affordable

Evidence-based guidelines ensure patient safety during perioperative management, especially as the use of these medications continues to surge

Diabetol Metab Syndr 16 , 293 (2024)

Clues from a two-step mendelian randomized study